期刊文献+

消渴丸联合二甲双胍对老年2型糖尿病伴脑微血管病变患者血液黏度、认知功能障碍的影响 被引量:4

Diabetes pill in combination with metformin on elderly patients with type 2 diabetes mellitus with cerebral microvascular lesion blood viscosity,the effects of cognitive dysfunction
下载PDF
导出
摘要 目的总结分析老年2型糖尿病伴脑微血管病变患者采用消渴丸联合二甲双胍治疗后对患者血液黏度、认知功能障碍的影响。方法铜川矿务局煤机医院2014年7月~2016年9月期间共接收100例老年2型糖尿病伴脑微血管病变患者,按照随机分配方法将其分为观察组(50例)和对照组(50例),对照组采用二甲双胍实施治疗,观察组采用消渴丸联合二甲双胍实施治疗,对2组患者的治疗效果以及相关指标进行比较分析。结果在治疗后的认知功能评分以及血液黏度相关指标方面,观察组和对照组之间差异具有统计学意义。结论老年2型糖尿病伴脑微血管病变患者在临床治疗中应用消渴丸联合二甲双胍,有助于改善患者的认知功能障碍,改善患者的血液黏度,促进患者的预后,值得推广应用。 Objective To summarize analysis in elderly patients with type 2 diabetes mellitus with cerebral microvascular lesion with diabetes pill in combination with metformin on patients after treatment the blood viscosity,the effects of cognitive dysfunction. Methods Our hospital during the period of July 2014 to September 2016 received 100 cases of elderly patients with type 2 diabetes mellitus with cerebral microvascular lesions,according to the random allocation method divided into observation group( 50 cases) and control group( 50 cases) and control group using metformin treatment,the observation group USES the diabetes pill metformin treatment,treatment effect of two groups of patients and related indicators for comparative analysis.Results After treatment the cognitive function score and blood viscosity related indicators,statistically significant differences between observation group and control group. Conclusion Elderly patients with type 2 diabetes mellitus with cerebral microvascular lesions in clinical application in diabetes,pill metformin,help to improve the patient's cognitive dysfunction,improve the patient's blood viscosity,promote the prognosis of patients,is worthy of popularization and application.
作者 赵景凤 贺嫚
出处 《中国生化药物杂志》 CAS 2017年第7期144-145,148,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 消渴丸 二甲双胍 老年2型糖尿病 脑微血管病变 血液黏度 认知功能障碍 diabetes pills metformin elderly with type 2 diabetes brain microvascular lesions blood viscosity cognitive dysfunction
  • 相关文献

参考文献10

二级参考文献60

  • 1张莉静,卢曦.基于PPAR抗糖尿病药物的研究进展[J].国外医学(药学分册),2004,31(5):287-291. 被引量:21
  • 2郑辉,于德民.糖尿病心肌病的发病机制和诊断[J].国际内分泌代谢杂志,2006,26(2):116-118. 被引量:11
  • 3陈慧.中西医结合治疗2型糖尿病60例[J].中国临床医生杂志,2006,34(9):51-52. 被引量:7
  • 4孙敏,孙晶,朱荃.复方HSF3对体外蛋白质非酶糖化反应的影响[J].中华中医药杂志,2006,21(10):622-623. 被引量:3
  • 5陈名道.脂毒性及其防治的一个关键靶点——AMPK[J].中华内分泌代谢杂志,2007,23(1):5-7. 被引量:13
  • 6中华人民共和国卫生部药政司冲药(新药)临床研究指导原则[M].北京:人民卫生出版社,1993:215.
  • 7Sivertsen J, Rosenmeier J, Holst J J, et al. The effect of gluca- gon-like peptidel on cardio-vascular risk [ J ]. Nat Rev Cardiol, 2012, 9(4) :209 -22.
  • 8Mu J, Woods J, Zhou Y P, et al. Chronic inhibition of dipeptidy peptidase-4 with a sitagliptin analog preserves pancreatic 13-cellmass and function in a rodent model of type 2 diabetes[ J]. Diabe- tes ,2006,55 ( 6 ) : 1695 - 1704.
  • 9Flock C, Baggio L L, Longuet C, et al. Incretin receptors for glu- cagon-like peptide 1 and glucose-dependent insulin otropic poly- peptide are essential for the sustained metabolication of vildagliptin in mice[J]. J Diabetes, 2007, 56(4): 3006-13.
  • 10Monami M, Lacomellil, Marchionni N, et al. Dipeptydil peptidase - 4 inhibitors in type 2 diabetes: ameta-analysis of randomized clini- cal trials[J]. Nun" Metab Cardiovase Dis,2010,20(4) : 224 -35.

共引文献122

同被引文献35

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部